1)吉田真奈子.アスピリンによる心血管病再発予防の実際.治療学 40:245-248, 2006
2) Yeomans ND, Lanas AI, Talley NJ, et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 22:795-801, 2005
3) Nema H, Kato M, Asaka M, et al. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.(in press)
4)小野尚子.低用量アスピリン7日間および単回投与における胃粘膜障害の検討―H. pylori陰性健常者における防御因子増強薬の予防効果について.北海道医誌 81:339-346, 2006
5)小平純一,小野尚子,加藤元嗣,他.低用量アスピリンによる胃粘膜障害―H. pylori陰性健常者による前向き比較試験.消化器科 38:466-470, 2004
6) Serrano P, Lanas A, Arroyo MT, et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 16:1945-1953, 2002
7)溝上裕士.低用量アスピリン起因性潰瘍についての検討.消化器科 38:459-465, 2004
8) Scheiman JM, Cryer B, Asaka M, et al. Panel Discussion:treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations. Aliment Pharmacol Ther Symp Ser 1:26-32, 2005
9) Garcia Rodriguez LA, Hernandez-Diaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Gastroenterol 159:23-31, 2004
10) Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346:2033-2038, 2002
11) Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344:967-973, 2001
12) Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 352:238-244, 2005
13)科学的根拠に基づく胃潰瘍診療ガイドラインの策定に関する研究班(編).EBMに基づく胃潰瘍診療ガイドライン.じほう,2007